Milestone scientific achieves 77% year-over-year increase in revenue to $2.9 million for the second quarter of 2023

Gross profit increases 178% compared to the same period last year new online store providing greater interaction with dentists and improved margins medical division reports positive reimbursement from first commercial payers roseland, n.j., aug. 15, 2023 (globe newswire) -- milestone scientific inc. (nyse: mlss), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the second quarter ended june 30, 2023.
MLSS Ratings Summary
MLSS Quant Ranking